MSB 6.07% $1.01 mesoblast limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-47

  1. 666 Posts.
    lightbulb Created with Sketch. 209
    @DocMcstuffins and @whytee

    I think you need to get your act together and start reading from the same hymn book.

    According to the Doc, the use of Temcell is saturated in Japan due to it being a small market. In other words, there can’t be any growth as it is being fully used already.

    However, according to Whytee, if efficacy is as good as suggested, then why isn’t everyone using it who could?

    A somewhat difference in views is it not? Seems to me you are arguing against each other. Now that would be a first, just like the FDA decision might be on Wednesday night.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.